Three patients in the Pradaxa group died (less than 1%), but two of these deaths were unrelated to blood clots.
Pradaxa rühmas suri kolm patsienti (vähem kui 1%), kuid kaks neist surmajuhtumitest ei olnud trombidega seotud.